Summary

● The company has poor fundamentals for a short-term investment strategy.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.


Weaknesses

● The stock is currently in contact with a medium-term resistance that must be gotten rid of so as to resume the upward trend.

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● The company's "enterprise value to sales" ratio is among the highest in the world.

● The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 101.18 times its estimated earnings per share for the ongoing year.

● The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.

● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.

● For the past seven days, analysts have been lowering their EPS expectations for the company.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

● The technical configuration over the long term remains negative on the weekly chart below the resistance level at 133.2 DKK